JS

Josh Sherman

Public/Private Biotech at Surveyor Capital (Citadel)

New York, New York

Work Experience

  • Public / Private Biotech Investor

    2022

2020 - 2022

  • Vice President, Biotech

    2020 - 2022

    Biotechnology Team Portfolio Responsibilities: Alpha-9 Theranostics, Avenge Bio, Inozyme (INZY), Lexeo Therapeutics, Sierra Oncology (SRRA), Theseus Pharmaceuticals (THRX)

2014 - 2019

  • Senior Associate

    2014 - 2019

    Apple Tree Partners (ATP) is a leading $2.5Bn life sciences venture capital firm dedicated to actively funding life sciences innovation and developing the next generation of transformative biotechnology companies. Senior Associate on the investment team focused on early to late-stage investments in biotechnology and medical devices.

2016 - 2019

  • Corporate Strategy & Finance

    2016 - 2019

    Braeburn is developing long-acting medicines for the treatment of opioid addiction.

2013 - 2014

  • Investment Banking, Healthcare

    2013 - 2014

    Healthcare Investment Banking Group

2012 - 2013

  • Investment Banking

    2012 - 2013

    Financial Institutions Group